ACCELERATE DIAGNOSTICS INC's ticker is AXDX and the CUSIP is 00430H102. A total of 118 filers reported holding ACCELERATE DIAGNOSTICS INC in Q2 2017. The put-call ratio across all filers is 0.69 and the average weighting 0.4%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Birchview Capital, LP | 4,387,590 | $46,772,000 | 15.62% |
| ORACLE INVESTMENT MANAGEMENT INC | 4,091,749 | $43,618,000 | 5.75% |
| GRIFFIN ASSET MANAGEMENT, INC. | 1,439,613 | $15,346,000 | 2.36% |
| Selkirk Management LLC | 348,805 | $3,718,000 | 1.18% |
| Chicago Capital, LLC | 1,966,891 | $20,967,000 | 1.08% |
| Trellus Management Company, LLC | 46,834 | $499,000 | 0.51% |
| Cannell & Co. | 1,118,439 | $11,923,000 | 0.44% |
| OAKTOP CAPITAL MANAGEMENT II, L.P. | 155,000 | $1,652,000 | 0.36% |
| Belpointe Asset Management LLC | 419,406 | $3,982,000 | 0.27% |
| TCI Wealth Advisors, Inc. | 55,586 | $593,000 | 0.23% |